Breast abscesses in nonlactating women with diabetes: Clinical features and outcome

American Journal of the Medical Sciences

Volumn 338, Issue 2, 2009, Pages 123-126

  Rizzo, Monica ^a   Peng, Limin ^b   Frisch, Anna ^c   Jurado, Maria ^c   Umpierrez, Guillermo ^c  

^a Avon Comprehensive Breast Center at Grady   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast abscess; Diabetes; Diabetic complications; Infections in diabetics; Lactation

Indexed keywords

ANTIBIOTIC AGENT; INSULIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST; BREAST ABSCESS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; INCISION; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL DRAINAGE; TEACHING HOSPITAL;

EID: 69349094925     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181a9d0d3     Document Type: Article

References (31)

1. Benson EA. Management of breast abscesses. World J Surg 1989;13:753-756
2. Devereux WP. Acute puerperal mastitis. Evaluation of its management. Am J Obstet Gynecol 1970;108:78-81.
3. Eryilmaz R, Sahin M, Hakan Tekelioglu M, et al. Management of lactational breast abscesses. Breast 2005;14:375-379
4. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253
5. Peleg AY, Weerarathna T, McCarthy JS, et al. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007;23:3-13.
6. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-288
7. Smitherman KO, Peacock JE Jr. Infectious emergencies in patients with diabetes mellitus. Med Clin North Am 1995;79:53-77.
8. Gupta S, Koirala J, Khardori R, et al. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am 2007;21:617-38, vii.
9. Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004;80:670-674
10. Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol 1977;103:600-604
11. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988;85:391-398
12. Garcia-Sancho Tellez L, Rodriguez-Montes JA, Fernandez de Lis S, et al. Acute emphysematous cholecystitis. Report of twenty cases. Hepatogastroenterology 1999;46:2144-2148
13. Joshi N, Caputo GM, Weitekamp MR, et al. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-1912
14. Thomas AA, Lane BR, Thomas AZ, et al. Emphysematous cystitis: a review of 135 cases. BJU Int 2007;100:17-20.
15. Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997;14:29-34.
16. Gallacher SJ, Thomson G, Fraser WD, et al. Neutrophil bactericidal function in diabetes mellitus: evidence for association with blood glucose control. Diabet Med 1995;12:916-920
17. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998;101:1905-1915
18. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072
19. Kim SH, Park KW, Kim YS, et al. Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism. Endothelium 2003;10:65-70.
20. Muchova J, Liptakova A, Orszaghova Z, et al. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus. Diabet Med 1999;16:74-78
21. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-982
22. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047
23. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31:359-366
24. Pomposelli JJ, Baxter JK III, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77-81.
25. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
26. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432
27. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-597
28. Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract 2004;10(suppl 2):89-99.
29. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478
30. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355:1903-1911
31. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006;129:644-650